Literature DB >> 11248023

Solution structure of the antiapoptotic protein bcl-2.

A M Petros1, A Medek, D G Nettesheim, D H Kim, H S Yoon, K Swift, E D Matayoshi, T Oltersdorf, S W Fesik.   

Abstract

The structures of two isoforms of Bcl-2 that differ by two amino acids have been determined by NMR spectroscopy. Because wild-type Bcl-2 behaved poorly in solution, the structures were determined by using Bcl-2/Bcl-x(L) chimeras in which part of the putative unstructured loop of Bcl-2 was replaced with a shortened loop from Bcl-x(L). These chimeric proteins have a low pI compared with the wild-type protein and are soluble. The structures of the two Bcl-2 isoforms consist of 6 alpha-helices with a hydrophobic groove on the surface similar to that observed for the homologous protein, Bcl-x(L). Comparison of the Bcl-2 structures to that of Bcl-x(L) shows that although the overall fold is the same, there are differences in the structural topology and electrostatic potential of the binding groove. Although the structures of the two isoforms of Bcl-2 are virtually identical, differences were observed in the ability of the proteins to bind to a 25-residue peptide from the proapoptotic Bad protein and a 16-residue peptide from the proapoptotic Bak protein. These results suggest that there are subtle differences in the hydrophobic binding groove in Bcl-2 that may translate into differences in antiapoptotic activity for the two isoforms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248023      PMCID: PMC30598          DOI: 10.1073/pnas.041619798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Establishing a degree of order: obtaining high-resolution NMR structures from molecular alignment.

Authors:  N Tjandra
Journal:  Structure       Date:  1999-09-15       Impact factor: 5.006

2.  Structure of Bax: coregulation of dimer formation and intracellular localization.

Authors:  M Suzuki; R J Youle; N Tjandra
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

Review 3.  From bench to clinic with apoptosis-based therapeutic agents.

Authors:  D W Nicholson
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

4.  Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells.

Authors:  J L Wang; Z J Zhang; S Choksi; S Shan; Z Lu; C M Croce; E S Alnemri; R Korngold; Z Huang
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

Review 5.  Bcl-2 and drugs used in the treatment of cancer: new strategies of biotherapy which should not be underestimated.

Authors:  A M Berghella; P Pellegrini; I Contasta; T Del Beato; D Adorno
Journal:  Cancer Biother Radiopharm       Date:  1998-08       Impact factor: 3.099

6.  Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

Authors:  A Bakhshi; J P Jensen; P Goldman; J J Wright; O W McBride; A L Epstein; S J Korsmeyer
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

7.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

Authors:  Y Tsujimoto; L R Finger; J Yunis; P C Nowell; C M Croce
Journal:  Science       Date:  1984-11-30       Impact factor: 47.728

8.  Equilibrium and kinetic inhibition assays based upon fluorescence polarization.

Authors:  W B Dandliker; M L Hsu; J Levin; B R Rao
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

9.  Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells.

Authors:  J L Wang; D Liu; Z J Zhang; S Shan; X Han; S M Srinivasula; C M Croce; E S Alnemri; Z Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

10.  Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

Authors:  M L Cleary; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

View more
  126 in total

1.  The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity.

Authors:  Mark G Hinds; Martin Lackmann; Gretchen L Skea; Penny J Harrison; David C S Huang; Catherine L Day
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

2.  A multimeric model for murine anti-apoptotic protein Bcl-2 and structural insights for its regulation by post-translational modification.

Authors:  Venkatarajan S Mathura; Kizhake V Soman; Tushar K Varma; Werner Braun
Journal:  J Mol Model       Date:  2003-08-30       Impact factor: 1.810

3.  Bcl-2 homodimerization involves two distinct binding surfaces, a topographic arrangement that provides an effective mechanism for Bcl-2 to capture activated Bax.

Authors:  Zhi Zhang; Suzanne M Lapolla; Matthew G Annis; Mary Truscott; G Jane Roberts; Yiwei Miao; Yuanlong Shao; Chibing Tan; Jun Peng; Arthur E Johnson; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

4.  The FKBP38 catalytic domain binds to Bcl-2 via a charge-sensitive loop.

Authors:  Katja Haupt; Günther Jahreis; Miriam Linnert; Mitcheell Maestre-Martínez; Miroslav Malesevic; Arndt Pechstein; Frank Edlich; Christian Lücke
Journal:  J Biol Chem       Date:  2012-04-20       Impact factor: 5.157

5.  Identification of a novel Mcl-1 protein binding motif.

Authors:  William J Placzek; Mattia Sturlese; Bainan Wu; Jason F Cellitti; Jun Wei; Maurizio Pellecchia
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

6.  Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX.

Authors:  Bonsu Ku; Chengyu Liang; Jae U Jung; Byung-Ha Oh
Journal:  Cell Res       Date:  2010-11-09       Impact factor: 25.617

7.  Bcl-2 and Bax interact via the BH1-3 groove-BH3 motif interface and a novel interface involving the BH4 motif.

Authors:  Jingzhen Ding; Zhi Zhang; G Jane Roberts; Mina Falcone; Yiwei Miao; Yuanlong Shao; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

Review 8.  The use of therapeutic peptides to target and to kill cancer cells.

Authors:  R J Boohaker; M W Lee; P Vishnubhotla; J M Perez; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

9.  Structure-based discovery of BM-957 as a potent small-molecule inhibitor of Bcl-2 and Bcl-xL capable of achieving complete tumor regression.

Authors:  Jianfang Chen; Haibin Zhou; Angelo Aguilar; Liu Liu; Longchuan Bai; Donna McEachern; Chao-Yie Yang; Jennifer L Meagher; Jeanne A Stuckey; Shaomeng Wang
Journal:  J Med Chem       Date:  2012-10-02       Impact factor: 7.446

Review 10.  Impact of the Protein Data Bank on antineoplastic approvals.

Authors:  John D Westbrook; Rose Soskind; Brian P Hudson; Stephen K Burley
Journal:  Drug Discov Today       Date:  2020-02-14       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.